You are here
John Paul Thottam is an Associate Scientist in Pfizer’s Rare Disease Research Unit, Neuromuscular Diseases. He attended Northeastern University where he studied Biochemistry and performed undergraduate research in the lab of Rebeca Rosengaus, investigating the immune responses of dampwood termites and tobacco hornworm moths. While a student at Northeastern, Mr. Thottam also participated in the Co-op program and worked for six months in Pfizer Cambridge’s Cardiovascular and Metabolic Diseases Research Unit on a project for small molecule mediated G-protein-coupled receptors sensitization. Upon graduation Mr. Thottam returned to Pfizer as a full time employee in the Neuromuscular group of the Rare Disease Research Unit. His work is currently focused on small molecule therapies for Duchenne’s Muscular Dystrophy.